Source:http://linkedlifedata.com/resource/pubmed/id/12560563
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0014644,
umls-concept:C0033684,
umls-concept:C0086418,
umls-concept:C0521447,
umls-concept:C0597357,
umls-concept:C1167622,
umls-concept:C1511545,
umls-concept:C1514562,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221,
umls-concept:C2242140,
umls-concept:C2826170
|
pubmed:issue |
Pt 2
|
pubmed:dateCreated |
2003-1-31
|
pubmed:abstractText |
Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) consists of W1W2 repeats and a unique C-terminal Y1Y2 domain and plays a critical role in EBV-induced transformation. To identify the cellular proteins associating with EBNA-LP, we performed a yeast two-hybrid screen using EBNA-LP cDNA containing a single W1W2 domain as bait and an EBV-transformed human peripheral blood lymphocyte cDNA library as the source of cellular genes. Our results were as follows. (i) A cDNA in the positive yeast colony was found to encode a cellular protein, human oestrogen-related receptor 1 (hERR1), which is a constitutive transcriptional activator of the various types of oestrogen response elements. (ii) A purified chimeric protein consisting of glutathione S-transferase (GST) fused to hERR1 specifically formed complexes with EBNA-LPs containing one (EBNA-LPR1), two (EBNA-LPR2) or four W1W2 repeats (EBNA-LPR4) transiently expressed in COS-7 cells. Reciprocally, GST fused to EBNA-LPR1 or EBNA-LPR2 pulled down hERR1 transiently expressed in COS-7 cells. (iii) Mutational analyses of EBNA-LP revealed that the Y2 domain of EBNA-LP is responsible for the interaction with hERR1 and two leucines in the Y2 domain (Leu-78 and -82), which are conserved among a subset of primate gammaherpesviruses, are interactive sites for hERR1. So far, it has been reported that the only domain of EBNA-LP critical for EBV-induced transformation is the Y1Y2 domain. Potential roles of hERR1 in EBV-induced transformation are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/EBNA-LP protein, Human herpesvirus 4,
http://linkedlifedata.com/resource/pubmed/chemical/ERRalpha estrogen-related receptor,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
319-27
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12560563-Amino Acid Sequence,
pubmed-meshheading:12560563-Animals,
pubmed-meshheading:12560563-B-Lymphocytes,
pubmed-meshheading:12560563-COS Cells,
pubmed-meshheading:12560563-Cell Transformation, Viral,
pubmed-meshheading:12560563-Conserved Sequence,
pubmed-meshheading:12560563-Gene Library,
pubmed-meshheading:12560563-Glutathione Transferase,
pubmed-meshheading:12560563-HeLa Cells,
pubmed-meshheading:12560563-Humans,
pubmed-meshheading:12560563-Molecular Sequence Data,
pubmed-meshheading:12560563-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:12560563-Receptors, Estrogen,
pubmed-meshheading:12560563-Recombinant Fusion Proteins,
pubmed-meshheading:12560563-Two-Hybrid System Techniques,
pubmed-meshheading:12560563-Viral Proteins
|
pubmed:year |
2003
|
pubmed:articleTitle |
Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization.
|
pubmed:affiliation |
Department of Tumor Virology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|